Protect Yourself from Stroke and Paralysis, Stay Ahead with a Carotid Doppler Ultrasound Screening
Carotid Doppler Ultrasound helps detect stroke risk early by assessing blood flow and artery narrowing. Stay protected with expert stroke screening.

Mild Cognitive Impairment (MCI) and the early stage of Alzheimer’s disease (AD) are conditions that affect memory, thinking, and daily activities. Detecting these conditions early is crucial because certain therapies, such as intravenous (IV) infusions, may help slow the progression of Alzheimer’s and improve quality of life.
MCI represents a stage between normal aging and dementia. People with MCI may begin to experience forgetfulness, difficulty concentrating, or challenges in performing routine tasks. While some cases of MCI remain stable, others gradually progress to Alzheimer’s disease, which is why early evaluation is crucial.
During the early stage of Alzheimer’s, symptoms such as memory loss, confusion about time or place, and difficulty finding words become more noticeable. At this stage, medical intervention can still play a role in maintaining function and independence, offering patients the chance to preserve their quality of life for longer.
Before starting the treatment, patients must undergo thorough evaluations to confirm the diagnosis and determine eligibility for therapies. These may include:
For some patients diagnosed in the early stages, IV infusion therapy may be recommended. These treatments are designed to target abnormal protein buildup in the brain, which is linked to the progression of Alzheimer’s disease. When started early, IV infusion therapy may help slow memory, thinking, and cognitive decline from Alzheimer’s disease.
Not every patient is a candidate for IV infusion therapy. A thorough consultation with a specialist is necessary to review medical history, genetic findings, and brain imaging results before treatment can begin. By seeking medical advice early, patients ensure that they receive safe, tailored, and effective care designed specifically for their condition.
Mild Cognitive Impairment and early-stage Alzheimer’s require timely evaluation and expert care. With advancements in diagnostic tools and IV infusion therapies, patients now have options that may slow disease progression and preserve quality of life. If you or a loved one is experiencing early signs of memory loss, consulting a doctor promptly is an essential step.
Early signs of Mild Cognitive Impairment (MCI) often include forgetfulness, difficulty focusing, losing track of conversations, or struggling to complete tasks that used to feel simple. These symptoms may be noticeable to family members before they become apparent to the patient.
MCI is not dementia, but it is considered a transitional stage between normal aging and dementia. Some individuals with MCI remain stable for years, while others progress to Alzheimer’s disease or another form of dementia.
Many people with MCI continue to live independently and maintain a normal lifestyle. While they may experience memory lapses or difficulty with problem-solving, lifestyle adjustments, regular medical follow-ups, and early treatments can help manage the condition effectively.
If you are diagnosed with MCI, the crucial step is to consult a specialist to identify the cause and monitor changes over time. Doctors may recommend lifestyle modifications, memory training, or treatments such as IV infusion therapy for those in the early stage of Alzheimer’s. Seeking early medical attention can make a significant difference in slowing the progression and maintaining quality of life.
Neuroscience Center, Vejthani International Hospital
Call: (+66)2-734-0000 Ext. 5400